SCHEMBL25820326

SCHEMBL25820326

CC(C)NC(=O)c1cccc(C(C)C)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.46
MLLT1 Q03111 1/20 0.43
CNR2 P34972 3/20 0.43
PARP1 P09874 1/20 0.43
ERN1 O75460 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TSHR P16473 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
CBLB Q13191 1/20 0.42
ALOX15 P16050 1/20 0.42
CASP1 P29466 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
P2RX7 Q99572 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
SCN9A Q15858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12986141 0.84 BRD4 (0.55) CNR1CNR2ALDH1A1CBLBP2RX7
SCHEMBL5688783 0.83 GRM5 (0.55) CNR1MLLT1PARP1ERN1ALDH1A1
SCHEMBL3105049 0.81 KDM4E (0.61) CNR1MLLT1ALDH1A1TSHRALOX15
SCHEMBL179305 0.81 MAPT (0.49) ALDH1A1TSHRNPC1RAB9ASMN1; SMN2
SCHEMBL20729958 0.81 BRD4 (0.55) CNR1MLLT1CNR2PARP1ERN1
SCHEMBL25676424 0.80 CBLB (0.41) CNR1CNR2ALDH1A1CBLBP2RX7
SCHEMBL18474392 0.80 CNR1 (0.43) CNR1CNR2PARP1ALDH1A1TSHR
SCHEMBL5241752 0.80 P2RX7 (0.43) CNR2ALDH1A1NPC1RAB9ACBLB
SCHEMBL27830227 0.80 KDM4E (0.41) ALDH1A1TSHRCBLBALOX15SMN1; SMN2
SCHEMBL31514785 0.79 CTSA (0.54) CNR1MLLT1PARP1ERN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA CNR1 2762/4885MLLT1 2608/4885CNR2 3121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.